A detailed history of State Of Wisconsin Investment Board transactions in Immunity Bio, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 105,923 shares of IBRX stock, worth $475,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,923
Previous 96,050 10.28%
Holding current value
$475,594
Previous $607,000 35.42%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.32 - $6.7 $32,778 - $66,149
9,873 Added 10.28%
105,923 $392,000
Q2 2024

Aug 14, 2024

SELL
$4.82 - $9.15 $310,123 - $588,720
-64,341 Reduced 40.12%
96,050 $607,000
Q1 2024

May 14, 2024

BUY
$3.23 - $6.17 $215,298 - $411,267
66,656 Added 71.11%
160,391 $861,000
Q4 2023

Feb 12, 2024

SELL
$1.25 - $5.21 $4,097 - $17,078
-3,278 Reduced 3.38%
93,735 $470,000
Q3 2023

Nov 14, 2023

SELL
$1.29 - $3.1 $1,715 - $4,123
-1,330 Reduced 1.35%
97,013 $163,000
Q2 2023

Aug 14, 2023

SELL
$1.53 - $6.41 $7,379 - $30,915
-4,823 Reduced 4.67%
98,343 $273,000
Q1 2023

May 15, 2023

SELL
$1.35 - $4.78 $15,539 - $55,022
-11,511 Reduced 10.04%
103,166 $187,000
Q4 2022

Feb 14, 2023

SELL
$4.35 - $6.77 $539,308 - $839,337
-123,979 Reduced 51.95%
114,677 $581,000
Q3 2022

Nov 14, 2022

SELL
$3.65 - $6.43 $274,965 - $484,391
-75,333 Reduced 23.99%
238,656 $1.19 Million
Q2 2022

Aug 15, 2022

BUY
$2.68 - $6.14 $609,670 - $1.4 Million
227,489 Added 262.99%
313,989 $1.17 Million
Q2 2021

Aug 12, 2021

BUY
$13.41 - $22.4 $590,040 - $985,599
44,000 Added 103.53%
86,500 $1.24 Million
Q1 2021

May 17, 2021

BUY
$12.83 - $42.25 $545,275 - $1.8 Million
42,500 New
42,500 $1.01 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.8B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.